BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36621839)

  • 21. Racial and Socioeconomic Disparities in the Treatments and Outcomes of Pancreatic Cancer Among Different Treatment Facility Types.
    Zhu F; Wang H; Ashamalla H
    Pancreas; 2020; 49(10):1355-1363. PubMed ID: 33122525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial disparities in patients with head and neck squamous cell carcinoma.
    Gourin CG; Podolsky RH
    Laryngoscope; 2006 Jul; 116(7):1093-106. PubMed ID: 16826042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base.
    Rutter CE; Park HS; Corso CD; Lester-Coll NH; Mancini BR; Yeboa DN; Johung KL
    Cancer; 2015 Dec; 121(23):4141-9. PubMed ID: 26280559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
    Albain KS; Unger JM; Crowley JJ; Coltman CA; Hershman DL
    J Natl Cancer Inst; 2009 Jul; 101(14):984-92. PubMed ID: 19584328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of malignant cutaneous granular cell tumors: A US population-based cohort analysis using the Surveillance, Epidemiology, and End Results (SEER) database.
    Mirza FN; Tuggle CT; Zogg CK; Mirza HN; Narayan D
    J Am Acad Dermatol; 2018 Mar; 78(3):490-497.e1. PubMed ID: 28989104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proportion of Early-Onset Gastric and Esophagus Cancers Has Changed Over Time With Disproportionate Impact on Black and Hispanic Patients.
    Torrejon NV; Deshpande S; Wei W; Tullio K; Kamath SD
    JCO Oncol Pract; 2022 May; 18(5):e759-e769. PubMed ID: 35544654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma.
    Murphy MM; Simons JP; Ng SC; McDade TP; Smith JK; Shah SA; Zhou Z; Earle CC; Tseng JF
    Ann Surg Oncol; 2009 Nov; 16(11):2968-77. PubMed ID: 19669839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stage-matched survival differences by ethnicity among gastric cancer patients of Asian ancestry treated in the United States.
    Rhome RM; Ru M; Moshier E; Mazumdar M; Buckstein MH
    J Surg Oncol; 2019 May; 119(6):737-748. PubMed ID: 30694524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duration of chemotherapy prior to chemoradiation affects survival outcomes for resected stage I-II or unresected stage III pancreatic cancer.
    Ma SJ; Iovoli AJ; Hermann GM; Prezzano KM; Singh AK
    Cancer Med; 2019 Aug; 8(9):4110-4123. PubMed ID: 31183965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: a multicenter study.
    Anderson MA; Zolotarevsky E; Cooper KL; Sherman S; Shats O; Whitcomb DC; Lynch HT; Ghiorzo P; Rubinstein WS; Vogel KJ; Sasson AR; Grizzle WE; Ketcham MA; Lee SY; Normolle D; Plonka CM; Mertens AN; Tripon RC; Brand RE
    Am J Gastroenterol; 2012 Nov; 107(11):1730-9. PubMed ID: 22929760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of affordable care act on the treatment and outcomes for stage-IV colorectal cancer.
    Jayakrishnan TT; Bakalov V; Chahine Z; Finley G; Monga D; Wegner RE
    Cancer Treat Res Commun; 2020; 24():100204. PubMed ID: 32805532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of pancreatic adenocarcinoma: disparity between African Americans and other race/ethnic groups.
    Chang KJ; Parasher G; Christie C; Largent J; Anton-Culver H
    Cancer; 2005 Jan; 103(2):349-57. PubMed ID: 15593353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of black/white differences in colon cancer survival.
    Mayberry RM; Coates RJ; Hill HA; Click LA; Chen VW; Austin DF; Redmond CK; Fenoglio-Preiser CM; Hunter CP; Haynes MA
    J Natl Cancer Inst; 1995 Nov; 87(22):1686-93. PubMed ID: 7473817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Socioeconomic Status Drives Racial Disparities in HPV-negative Head and Neck Cancer Outcomes.
    Lenze NR; Farquhar D; Sheth S; Zevallos JP; Blumberg J; Lumley C; Patel S; Hackman T; Weissler MC; Yarbrough WG; Zanation AM; Olshan AF
    Laryngoscope; 2021 Jun; 131(6):1301-1309. PubMed ID: 33170518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in outcome for patients with cholangiocarcinoma: Racial/ethnic disparity or socioeconomic factors?
    Lee RM; Liu Y; Gamboa AC; Staley CA; Kooby D; Russell MC; Cardona K; Maithel SK
    Surg Oncol; 2020 Sep; 34():126-133. PubMed ID: 32891317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elucidating Determinants of Survival Disparities Among a Real-world Cohort of Metastatic Breast Cancer Patients: A National Cancer Database Analysis.
    Statler AB; Wei W; Gupta A; Blake CN; Hobbs BP; Nahleh ZA
    Clin Breast Cancer; 2020 Oct; 20(5):e625-e650. PubMed ID: 32434711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and comparative outcomes of periampullary cancer: A population-based analysis demonstrating improved outcomes and increased use of adjuvant therapy from 2004 to 2012.
    Hester CA; Dogeas E; Augustine MM; Mansour JC; Polanco PM; Porembka MR; Wang SC; Zeh HJ; Yopp AC
    J Surg Oncol; 2019 Mar; 119(3):303-317. PubMed ID: 30561818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disparities in Survival Due to Social Determinants of Health and Access to Treatment in US Patients With Operable Malignant Pleural Mesothelioma.
    Alnajar A; Kareff SA; Razi SS; Rao JS; De Lima Lopes G; Nguyen DM; Villamizar N; Rodriguez E
    JAMA Netw Open; 2023 Mar; 6(3):e234261. PubMed ID: 36951862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Racial Disparities and Trends in Pancreatic Cancer Incidence and Mortality in the United States.
    Tavakkoli A; Singal AG; Waljee AK; Elmunzer BJ; Pruitt SL; McKey T; Rubenstein JH; Scheiman JM; Murphy CC
    Clin Gastroenterol Hepatol; 2020 Jan; 18(1):171-178.e10. PubMed ID: 31202981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Glycated Hemoglobin Levels With Risk of Pancreatic Cancer.
    Wu BU; Butler RK; Lustigova E; Lawrence JM; Chen W
    JAMA Netw Open; 2020 Jun; 3(6):e204945. PubMed ID: 32530471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.